1,2,3-Triazole derivatives enable therapeutic and diagnostic strategies for neurodegenerative diseases

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease or Multiple Sclerosis are characterized by progressive loss of neuronal structure and function, and current therapies remain purely symptomatic, offering no disease-modifying benefit. This challenge has driven the development towards rationally designed 1,2,3-triazole hybrid molecules for the treatment and diagnosis of these disorders. 1,2,3-triazole derivatives are synthesized reliably through copper-catalyzed azide-alkyne cycloaddition, termed click reaction, and acting either as a stable structural linker between two independent pharmacophores or as an active pharmacological contributor. In this review, we provide a comprehensive overview of the recent development of 1,2,3-triazole derivatives investigated for Alzheimer’s disease, Parkinson’s disease and Multiple Sclerosis with particular emphasis on their structural features, biological targets and pharmacological properties. The reviewed compounds exhibit a broad range of activities relevant to neurodegeneration, including cholinesterase inhibition, adenosine receptor antagonism, modulation of oxidative stress and neuroinflammation, inhibition of protein aggregation, and interaction with disease-associated molecular targets. The versatility of the 1,2,3-triazole scaffold enables the combination of complementary pharmacophores and even the generation of multitarget-directed compounds. In addition, 1,2,3-triazole scaffolds facilitate blood brain barrier penetration and enhance drug metabolic stability. Overall, 1,2,3-triazole derivatives represent a versatile chemical platform for the exploration of multifunctional strategies against neurodegenerative disorders and provide opportunities for the future design of new therapeutic candidates.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-19
DOI
https://doi.org/10.3389/fphar.2026.2006105
Primary Topic
Click Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

1,2,3-Triazole derivatives enable therapeutic and diagnostic strategies for neurodegenerative diseases

I. Posadas, J. Rubio-Sanz, M. D. Perez-Carrion
Frontiers in Pharmacology
Click Chemistry and Applications
article

1,2,3-Triazole derivatives enable therapeutic and diagnostic strategies for neurodegenerative diseases

I. Posadas, J. Rubio-Sanz, M. D. Perez-Carrion
article en

Abstract

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease or Multiple Sclerosis are characterized by progressive loss of neuronal structure and function, and current therapies remain purely symptomatic, offering no disease-modifying benefit. This challenge has driven the development towards rationally designed 1,2,3-triazole hybrid molecules for the treatment and diagnosis of these disorders. 1,2,3-triazole derivatives are synthesized reliably through copper-catalyzed azide-alkyne cycloaddition, termed click reaction, and acting either as a stable structural linker between two independent pharmacophores or as an active pharmacological contributor. In this review, we provide a comprehensive overview of the recent development of 1,2,3-triazole derivatives investigated for Alzheimer’s disease, Parkinson’s disease and Multiple Sclerosis with particular emphasis on their structural features, biological targets and pharmacological properties. The reviewed compounds exhibit a broad range of activities relevant to neurodegeneration, including cholinesterase inhibition, adenosine receptor antagonism, modulation of oxidative stress and neuroinflammation, inhibition of protein aggregation, and interaction with disease-associated molecular targets. The versatility of the 1,2,3-triazole scaffold enables the combination of complementary pharmacophores and even the generation of multitarget-directed compounds. In addition, 1,2,3-triazole scaffolds facilitate blood brain barrier penetration and enhance drug metabolic stability. Overall, 1,2,3-triazole derivatives represent a versatile chemical platform for the exploration of multifunctional strategies against neurodegenerative disorders and provide opportunities for the future design of new therapeutic candidates.

Frontiers in PharmacologyVol. 17
Instituto de Salud Carlos III (ES), University of Castilla-La Mancha (ES)
Click Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon